Progressive functional decline in the epilepsies is largely unexplained. We formed the ENIGMA-Epilepsy consortium to understand factors that influence brain measures in epilepsy, pooling data from 24 research centres in 14 countries across Europe, North and South America, Asia, and Australia. Structural brain measures were extracted from MRI brain scans across 2149 individuals with epilepsy, divided into four epilepsy subgroups including idiopathic generalized epilepsies (n =367), mesial temporal lobe epilepsies with hippocampal sclerosis (MTLE; left, n = 415; right, n = 339), and all other epilepsies in aggregate (n = 1026), and compared to 1727 matched healthy controls. We ranked brain structures in order of greatest differences between patients and controls, by metaanalysing effect sizes across 16 subcortical and 68 cortical brain regions. We also tested effects of duration of disease, age at onset, and age-by-diagnosis interactions on structural measures. We observed widespread patterns of altered subcortical volume and reduced cortical grey matter thickness. Compared to controls, all epilepsy groups showed lower volume in the right thalamus 
Introduction
Epilepsy is a prevalent neurological disorder, comprising many different syndromes and conditions, affecting 0.6-1.5% of the population worldwide (Bell et al., 2014) . Approximately one-third of affected individuals do not respond to antiepileptic drug therapy (French, 2007) . Alternative treatment options may not be appropriate (Englot et al., 2011) , and are not always effective (Téllez-Zenteno et al., 2005; Englot et al., 2011) . The identification of shared biological disease pathways may help elucidate diagnostic and prognostic biomarkers and therapeutic targets, which, in turn, could help to optimize individual treatment (Pitkä nen et al., 2016) . However, disease biology remains unexplained for most cases-especially in commonly occurring epilepsies.
Epilepsy is a network disorder typically involving widespread structural alterations beyond the putative epileptic focus (Bernhardt et al., 2015; Vaughan et al., 2016) . Hippocampal sclerosis is a common pathological substrate of mesial temporal lobe epilepsy (MTLE), but extrahippocampal abnormalities are also frequently observed in MTLE, notably in the thalamus (Keller and Roberts, 2008; Coan et al., 2014; Alvim et al., 2016) and neocortex (Keller and Roberts, 2008; Bernhardt et al., 2009b Bernhardt et al., , 2010 Blanc et al., 2011; Labate et al., 2011; Vaughan et al., 2016) . Neocortical abnormalities are also reported in idiopathic generalized epilepsies (IGE) (Bernhardt et al., 2009a) , and many childhood syndromes Vollmar et al., 2011; Ronan et al., 2012; Overvliet et al., 2013) . Thus, common epilepsies may be characterized by shared disturbances in distributed cortico-subcortical brain networks (Berg et al., 2010) , but the pattern, consistency and cause of these disturbances, and how they relate to functional decline (Vlooswijk et al., 2010; Bernasconi, 2016; Nickels et al., 2016) , are largely unknown.
Currently, we lack reliable data from large cross-sectional neuroimaging, brain tissue, or biomarker studies in the common epilepsies. Brain tissue is not available from large cohorts of patients: common forms of epilepsy are often unsuitable for surgical treatment, so biopsied tissues are simply unavailable in sufficient numbers for research into disease biology. Brain-wide post-mortem studies also require extensive effort for comprehensive analysis. MRI offers detailed information on brain structure, but MRI measures from groups of individuals with and without epilepsy are not always consistent. For example, MTLE is associated with hippocampal sclerosis in up to 70% of brain MRI scans (Blü mcke et al., 2013) . However, the effects of laterality, and the extent of extrahippocampal grey matter loss are inconsistently reported in studies of left versus right MTLE (Kemmotsu et al., 2011; Liu et al., 2016) . Similarly, abnormalities of the basal ganglia, hippocampus, lateral ventricles, and neocortex have all been reported in IGE (Betting et al., 2006) , but most alterations are non-specific, and visual inspection of clinical MRI in IGE is typically normal (Woermann et al., 1998) . Genomewide association studies (GWAS) have identified genetic variants associated with complex epilepsies by 'lumping' different epilepsy types together (International League Against Epilepsy Consortium on Complex Epilepsies, 2014), but MRI studies are typically of smaller scale, and have not widely explored whether distinct epilepsy syndromes share common structural abnormalities.
There are many sources of inconsistency in previously reported MRI findings. First, epileptic seizures and syndromes are diverse; classifications are often revised and contested (Berg et al., 2010; Scheffer et al., 2017) . Second, most cross-sectional brain imaging studies are based on small samples (typically 550 cases), limiting the power to detect subtle group differences (Button et al., 2013) . Third, variability in scanning protocols, image processing, and statistical analysis may affect the sensitivity of brain measures across studies.
The Enhancing Neuro Imaging Genetics through MetaAnalysis (ENIGMA) Consortium was formed to address these issues . ENIGMA is a global initiative, combining large samples with coordinated image processing, and integrating genomic and MRI data across hundreds of research centres worldwide. Prior ENIGMA studies have identified genetic variants associated with variations in brain structure (Stein et al., 2012; Hibar et al., 2015 Hibar et al., , 2017a Adams et al., 2016) , and have reliably characterized patterns of brain abnormalities in schizophrenia , major depression (Schmaal et al., 2016) , obsessive compulsive disorder , attention deficit hyperactivity disorder (Hoogman et al., 2017) , and many other brain illnesses . Large-scale, collaborative initiatives such as ENIGMA may improve our understanding of epilepsy, helping clinicians make more informed decisions and provide personalized treatment strategies (Ben-Menachem, 2016) . Thus, we formed the Epilepsy Working Group of ENIGMA ('ENIGMA-Epilepsy') to apply coordinated, well-powered studies of imaging and genetic data in epilepsy.
Here, in the largest analysis of structural brain abnormalities in epilepsy to date, we ranked effect sizes for 16 subcortical and 68 cortical brain regions in 2149 individuals with epilepsy and 1727 healthy controls, using harmonized image processing, quality control, and meta-analysis. First, we grouped all epilepsies together, to determine whether biologically distinct syndromes show robust, common structural deficits. Second, we assessed a wellcharacterized form of epilepsy: MTLE with hippocampal sclerosis, analysing patients with left-and right-sided hippocampal sclerosis as independent groups. Third, we examined another major set of epilepsy syndromes: IGE. Finally, we studied all remaining epilepsies as a combined subgroup, to understand the relative contributions of IGE, MTLE-L, MTLE-R, and all other syndromes on shared patterns of structural compromise. We tested how age at scan, age of onset, and epilepsy duration affected brain structural measures. Based on existing neuroimaging (Gotman et al., 2005; Bernhardt et al., 2009a; Liu et al., 2016) , neurophysiological (Gotman et al., 2005) , neuropathological (Thom et al., 2009) , and genetic data (International League Against Epilepsy Consortium on Complex Epilepsies, 2014), we predicted that (i) biologically distinct epilepsy syndromes would exhibit shared patterns of structural abnormalities; (ii) MTLEs with left or right hippocampal sclerosis would show distinct patterns of hippocampal and extrahippocampal structural deficits; and (iii) IGEs would also display subcortical volume and cortical thickness differences, compared to healthy controls.
Materials and methods
Each centre received approval from their local institutional review board or ethics committee. Written informed consent was provided according to local requirements (Supplementary Table 1 ).
Experimental design Participants
Twenty-four cross-sectional samples from 14 countries were included in the study, totalling 2149 people with epilepsy and 1727 research centre-matched healthy control subjects ( Fig. 1 and Table 1 ). The locations, dates, and periods of participant recruitment are provided in Supplementary Table 1 . An epilepsy specialist assessed seizure and syndrome classifications at each centre, using International League Against Epilepsy terminology (Berg et al., 2010) . Participants were aged 18-55.
To test for shared and syndrome-specific structural alterations, analyses included one group combining all epilepsies ('all-epilepsies'; n = 2149), and four stratified subgroups: (i) left MTLE with left hippocampal sclerosis (MTLE-L; n = 415); (ii) right MTLE with right hippocampal sclerosis (MTLE-R; n = 339); (iii) IGE (n = 367); and (iv) all other epilepsies (n = 1028). Supplementary Table 2 lists all syndromic diagnoses included in the aggregate 'all-epilepsies' group. For the MTLE subgroups, we included anyone with the typical electroclinical constellation (Berg et al., 2010) , and a neuroradiologically-confirmed diagnosis of unilateral hippocampal sclerosis on clinical MRI. Participants were included in the IGE subgroup if they presented with tonic-clonic, absence or myoclonic seizures with generalized spike-wave discharges on EEG. Participants were included in the 'all-other-epilepsies' subgroup if they were diagnosed with non-lesional MTLE (43.3%), occipital (1.67%), frontal (8.78%), or parietal lobe epilepsy (0.84%), focal epilepsies not otherwise specified (37.03%), or another unclassified syndrome (8.37%; Supplementary Table 2) . We excluded participants with a progressive disease (e.g. Rasmussen's encephalitis), malformations of cortical development, tumours or previous neurosurgery.
MRI data collection and processing
Structural T 1 -weighted MRI brain scans were collected at the 24 participating centres. Scanning details are provided in Supplementary Table 3 . T 1 -weighted images from cases and controls were analysed at each site using FreeSurfer 5.3.0, for automated analysis of brain structure (Fischl, 2012) . Volumetric measures were extracted for 12 subcortical grey matter regions (six left and six right, including the amygdala, caudate, nucleus accumbens, pallidum, putamen, and thalamus), the left and right hippocampi, and the left and right lateral ventricles. Cortical thickness measures were extracted for 34 left-hemispheric grey matter regions, and 34 right-hemispheric grey matter regions (68 total; Supplementary Table 4). Visual inspections of subcortical and cortical segmentations were conducted following standardized ENIGMA protocols (http://enigma.usc.edu), used in prior genetic studies of brain structure (Stein et al., 2012; Hibar et al., 2015 Hibar et al., , 2017a Adams et al., 2016) , and large-scale case-control studies of neuropsychiatric illnesses (Schmaal et al., 2015 (Schmaal et al., , 2016 Hibar et al., 2016; van Erp et al., 2016; Boedhoe et al., 2017) . Analysts were blind to participants' diagnoses. Each analyst was instructed to execute a series of standardized bash scripts, identifying participants with volumetric or thickness measures greater or less than 1.5 times the interquartile range as outliers. Outlier data were then visually inspected, by overlaying the participant's cortical segmentations on their whole-brain anatomical images. If the blinded local analyst judged any structure as inaccurately segmented, that structure was omitted from the analysis. The Supplementary material provides further information.
Statistical analysis Participant demographics
All research centres tested for differences in age between individuals with epilepsy and controls using an unpaired, twotailed t-test in the R statistics package (https://www.r-project. org). Each centre also tested for sex differences between individuals with epilepsy and controls using a chi-squared test in SPSS Statistics package (IBM Corp., Version 21.0).
Meta-analytical group comparisons
Each research centre tested for case-versus-control differences using multiple linear regressions (via the lm function implemented in R), where a binary indicator of diagnosis (0 = healthy control, 1 = person with epilepsy) was the predictor of interest, and the volume or thickness of a specified brain region was the outcome measure. We calculated effect size estimates across all brain regions using Cohen's d, adjusting for age, sex and intracranial volume (ICV). ICV is a reliable, indirect measure of head size (Hansen et al., 2015) , used as a covariate in other large-scale ENIGMA collaborations (Schmaal et al., 2015 (Schmaal et al., , 2016 Hibar et al., 2016; van Erp et al., 2016; Boedhoe et al., 2017 ). Cohen's d effect sizes and regression beta coefficients were pooled across centres using a random-effects, restricted maximum likelihood method of meta-analysis via the R package, metafor (Viechtbauer, 2010) . The Supplementary material provides additional details.
Meta-analytical regression with clinical variables
Each centre conducted a series of linear regressions, testing the association between subcortical volume or cortical thickness, and: (i) age at onset of epilepsy; and (ii) duration of epilepsy. Also provided is the total number of MTLE cases with left hippocampal sclerosis, MTLE cases with right hippocampal sclerosis, IGE and all-other-epilepsies ('other') cases per site. Research centres with fewer than five participants for a given phenotype are marked as '0' for that phenotype, with the original sample size noted in parentheses. SD = standard deviation.
All centres tested for interactions between diagnosis of epilepsy (including syndrome groups) and age at time of scan. Beta values representing the unstandardized slopes of each regression were extracted for each analysis. Sex and ICV were included as covariates in all secondary analyses.
Correction for multiple comparisons
We conducted four independent regressions (one case versus control regression, and three regressions with clinical variables) across 84 regions of interest, adjusting the statistical significance threshold to P thresh 5 1.49 Â 10 À4 to correct for 336 comparisons. To account for correlations between tests, we also applied a less conservative adjustment for false discovery rate (FDR), using the Benjamini and Hochberg method (Benjamini and Hochberg, 1995) . For clarity, we report only P-values significant after stringent Bonferroni correction; FDR-adjusted P-values are summarized in the Supplementary material.
Power analyses
Across all regions of interest, we calculated the sample sizes necessary to achieve 80% power to detect case-control differences, given the observed effect sizes at each region of interest, based on two-tailed t-tests, using G*Power Version 3.1. For each region of interest, we also estimated N 80 : the total number of samples required, per group, to achieve 80% power to detect group differences using a t-test at the threshold of P 5 0.05 (two-tailed).
Results

Participant demographics
The sample size-weighted mean age across all epilepsy samples was 34.4 (range: 26.2-40) years, and the weighted mean age of healthy controls was 33.3 (range: 25.2-42.3) years. The weighted mean age at onset of epilepsy and duration of epilepsy were 17.6 (range: 12.1-28.2) years and 17.4 (range: 8.3-28) years, respectively. Females comprised 57% of the total epilepsy sample (range: 34-75% by individual sample), and 53% of the controls (range: 31-71% by individual sample). Case-control differences in age were observed at 8 of 24 research centres, and case-control differences in sex were observed at 2 of 24 research centres (Supplementary Table 5 ); hence, age and sex were included as covariates in all group comparisons.
Volumetric findings
Compared to controls, the aggregate all-epilepsies group exhibited lower volumes in the left (d = À0.36; P = 1.31 Â 10 ) lateral ventricles were enlarged across all epilepsies when compared to controls (Table 2 and Fig. 2A) . A supplementary analysis of all-epilepsies, excluding individuals with hippocampal sclerosis or other lesions, revealed similar patterns of volume loss in the right thalamus and pallidum, and bilaterally enlarged ventricles; however, volume differences were not observed in the hippocampus (Supplementary Table 6 (Table 2 and Fig. 2C ).
The IGE subgroup showed lower volumes in the right thalamus (d = À0.4; P = 3.6 Â 10 À6 ) compared to controls (Table 2 and Fig. 2D) .
The all-other-epilepsies subgroup showed lower volumes in the right thalamus (d = À0.31; P = 7.9 Â 10 (Table 2 and Fig. 2E ).
All volume differences can be visualized using the interactive ENIGMA-Viewer tool (Zhang et al., 2017) , at http://enigma-viewer.org/ENIGMA_epilepsy_subcortical.html (Supplementary material). Volume differences significant after FDR adjustment can also be visualized at http:// enigma-viewer.org/ENIGMA_epilepsy_subcortical_fdr.html (Supplementary Tables 26-30 ).
Cortical thickness findings
The all-epilepsies group showed reduced thickness of cortical grey matter across seven regions bilaterally, including the left (d = À0.38; P = 1.82 Â 10 À18 ) and right precentral gyri (d = À0.4; P = 8.85 Â 10 supramarginal gyri (d = À0.22; P = 5.24 Â 10
À5
). The allepilepsies group also showed unilaterally thinner right cuneus (d = À0.2; P = 9.68 Â 10 ), compared to healthy controls (Table 3 and Fig. 3A) . Supplementary analysis in a non-lesional epilepsy subgroup revealed a similar pattern of cortical thickness differences compared to controls, suggesting that the changes observed in our main analysis were not driven by the inclusion of patients with hippocampal sclerosis or other common lesions (Supplementary Table 7 ).
The MTLE-L and MTLE-R subgroups showed distinct patterns of cortical thickness reductions when compared to healthy controls (Table 3 , Fig. 3B and C) . In MTLE-R, lower cortical thickness was reported across four motor regions, including the left (d = À0.51; P = 7.67 Â 10 (Table 3 and Fig. 3C ). By contrast, in MTLE-L, lower thickness was observed across six regions of the motor cortex, including the left (d = À0.43; P = 1.61 Â 10
) and right paracentral gyri (d = À0.38; P = 5.14 Â 10 (Table 3 and Fig. 3B ). The IGE subgroup showed reduced thickness in the left (d = À0.34; P = 1.75 Â 10
À6
) and right precentral gyri (d = À0.39; P = 5.27 Â 10 À8 ), when compared to healthy controls (Table 3 and Fig. 3D) .
The all-other-epilepsies subgroup showed lower thickness across six cortical regions bilaterally, including the left (d = À0.38; P = 1.76 Â 10 ), compared to controls (Table 3 and Fig. 3E ).
An interactive 3D visualization of these results is available via the ENIGMA-Viewer tool (Zhang et al., 2017) , at http://enigma-viewer.org/ENIGMA_epilepsy_cortical.html (Supplementary material). Cortical thickness differences significant after FDR adjustment can also be visualized at http://enigma-viewer.org/ENIGMA_epilepsy_cortical_ fdr.html (Supplementary Tables 31-35 ).
Duration of illness, age at onset, and age-by-diagnosis effects on brain abnormalities
A secondary analysis identified significant associations between duration of epilepsy and several affected brain regions in the all-epilepsies, MTLE-R, and all-other-epilepsies groups. In the all-epilepsies group, duration of epilepsy negatively associated with volume measures in the left hippocampus (b = À8.32; P = 8.16 Â 10 Age at onset negatively associated with other regional volumetric and thickness measures in the all-epilepsies, IGE, MTLE-L, MTLE-R, and all-other-epilepsies groups, but these associated areas showed no significant structural differences in the primary case-control analysis (Table 1  and Supplementary Table 8 ).
There were no interaction effects between age and syndromic diagnosis in the all-epilepsies, MTLE-L, MTLE-R, IGE, or all-other-epilepsies groups.
Power analyses for detection of case-control differences
In our sample of 2149 individuals with epilepsy and 1727 healthy controls, we had 80% power to detect Cohen's d effect sizes as small as d = 0.091 at the standard alpha level of P 5 0.05 (two-tailed), and 80% power to detect Cohen's d effect sizes as small as d = 0.149 at the study's stringent Bonferroni-corrected threshold of P 5 1.49 Â 10
À4
. N 80 , the number of cases and controls required to achieve 80% power to detect group differences using a two-tailed t-test at P 5 0.05, ranged from N 80 = 6, to detect group effects in the right hippocampus in our MTLE-R group, to N 80 = 503, to detect group effects in the right pars opercularis in our 'all epilepsies' group (Tables 2 and 3) .
Discussion
In the largest coordinated neuroimaging study of epilepsy to date, we identified a series of quantitative imaging signatures-some shared across common epilepsy syndromes, and others characteristic of selected, specific epilepsy syndromes. Our sample of 2149 individuals with epilepsy and 1727 controls provided 80% power to detect differences as small as d = 0.091 (P 5 0.05, two-tailed), allowing us to identify subtle, consistent brain abnormalities that are typically undetectable on visual inspection, or overlooked using smaller case-control designs. This international collaboration addresses prior inconsistencies in the field of epilepsy neuroimaging, providing a robust, in vivo map of structural aberrations, upon which future studies of disease mechanisms may expand.
In the first of five cross-sectional MRI analyses, we investigated a diverse aggregation of epilepsy syndromes, putative causes, and durations of disease. This all-epilepsies group exhibited shared, diffuse brain structural differences across several regions including the thalamus, pallidum, precentral, paracentral, and superior frontal cortices. With the exception of hippocampal volume and entorhinal thickness differences (Supplementary material), these structural alterations were not driven by any specific syndrome or dataset ( Supplementary Figs 3 and 7) . Our findings suggest a common neuroanatomical signature of epilepsy across a wide spectrum of disease types, complementing recent evidence for shared genetic susceptibility to a wide spectrum of epilepsies (International League Against Epilepsy Consortium on Complex Epilepsies, 2014). Some structural and genetic pathways may be shared across syndromes, despite the heterogeneity of epilepsy and seizure types. This shared MRI signature underpins the contemporary shift towards the study of epilepsies as network phenomena (Caciagli et al., 2014) .
In MTLE, as expected, we observed hippocampal volume abnormalities ipsilateral to the patient's side of seizure onset. Neither MTLE-L nor MTLE-R showed significant contralateral hippocampal volume reductions, confirming that sporadic, unilateral MTLE is not routinely underpinned by bilateral hippocampal damage (Blü mcke et al., 2013) . Both MTLE groups showed extrahippocampal abnormalities in the ipsilateral thalamus and pallidum, with widespread reductions in cortical thickness, supporting a growing body of literature indicating that MTLE, as an example of a specific disease constellation in the epilepsies, is also a network disease, extending beyond the mesial temporal regions (Keller et al., 2014; de Campos et al., 2016) . Disruption of this network, notably in the thalamus (Keller et al., 2015; He et al., 2017) and thalamo-temporal white matter tracts (Keller et al., 2015 (Keller et al., , 2017 , may be associated with postoperative seizure outcome in MTLE.
Patients with left and right MTLE showed distinct patterns of structural abnormalities when compared to controls, resolving conflicting findings from smaller studies, some reporting an equal distribution of structural differences (Liu et al., 2016) , and others indicating more diffuse abnormalities, either in left MTLE (Keller et al., 2002 (Keller et al., , 2012 Bonilha et al., 2007; Kemmotsu et al., 2011; de Campos et al., 2016) or in right MTLE (Pail et al., 2009) . The structural differences observed in the present study may reflect a younger age at onset of epilepsy in left MTLE, which occurred, on average, 1.2 years earlier than those with right MTLE (Supplementary Table 20) . Independent, large-scale studies of MTLE patients have confirmed a significantly earlier age at onset in left, compared to right, MTLE (Blü mcke et al., 2017) . Durationrelated effects were also observed in right, but not left, MTLE, pointing to possible biological distinctions between the two.
In IGE, a clinically and biologically distinct group of epilepsies typically associated with 'normal' MRI on clinical inspection (Woermann et al., 1998) , we identified reduced volume of the right thalamus, and thinner precentral gyri in both hemispheres, supporting prior reports of structural (Bernhardt et al., 2009a) , electroencephalographic, and functional (Gotman et al., 2005) abnormalities in IGE. These IGE cases were considered typical by reviewing neurologists, suggesting that this common type of epilepsy is also associated with quantifiable structural brain abnormalities.
The precentral gyri, site of the primary motor cortex, showed bilateral structural deficits across all epilepsy groups (all-epilepsies, IGE, MTLE-L, MTLE-R, and allother-epilepsies), without detectable inter-cohort or between-disease heterogeneity (Supplementary Figs 3-12) .
Atrophy of the motor cortex has been linked to seizure frequency and duration of epilepsy in MTLE (Coan et al., 2014) ; here, we observed a negative correlation between precentral (and postcentral) grey matter thickness and duration of epilepsy in the aggregate all-epilepsies group.
The right thalamus also showed evidence of structural compromise across all epilepsy cohorts, re-emphasizing the importance of the thalamus as a major hub in the epilepsy network (He et al., 2017; Jobst and Cascino, 2017) . Loss of feed-forward inhibition between the thalamus and its neocortical connections may be epileptogenic (Paz and Huguenard, 2015) , and thalamocortical abnormalities have previously been reported in IGE (Gotman et al., 2005; Bernhardt et al., 2009a; O'Muircheartaigh et al., 2012) and MTLE (Mueller et al., 2010; Bernhardt et al., 2012) . These findings support prior 'system epilepsies' hypotheses of pathophysiology (Avanzini et al., 2012) , suggesting that a broad range of common epilepsies share vulnerability within a thalamocortical structural pathway involved in, and likely affected by, seizures (Liu et al., 2003; Bernhardt et al., 2013) . Given this study's cross-sectional design, we cannot determine if these are causative changes, consequences of recurrent seizures, prolonged drug treatment, or a combination of factors. The epilepsies, as a broad group, may involve progressive structural change (Caciagli et al., 2017) , indicating the need for large-scale longitudinal studies.
A heterogeneous subgroup of individuals without confirmed diagnoses of IGE or MTLE with hippocampal sclerosis showed similar patterns of structural alterations to those observed in the aggregate all-epilepsies cohort. The findings included enlarged ventricles, smaller right pallidum and right thalamus, and reduced thickness across the motor and frontal cortices. Hippocampal abnormalities were not observed in this subgroup, suggesting that the patterns of reduced hippocampal grey matter observed in the aggregate group were driven by the inclusion of MTLEs with hippocampal sclerosis. Unlike the IGE, MTLE, and aggregate epilepsy cohorts, this subgroup also showed bilateral enlargement of the amygdala-a phenomenon previously reported in non-lesional localization-related epilepsies (Reyes et al., 2017) and non-lesional MTLEs (Takaya et al., 2012; Coan et al., 2013) . Non-lesional MTLEs formed a large proportion of this 'all-other-epilepsies' cohort (43.3%; 445 individuals), but the subgroup included many other focal and unclassified syndromes, potentially obscuring specific biological interpretations. Future, sufficiently powered studies will stratify this cohort into finer-grained subtypes to delineate syndrome-specific effects.
Despite its international scale, our study has limitations. All results were derived from cross-sectional data: we cannot distinguish between historical acute damage and progressive abnormalities. We cannot disentangle the relative contributions of environmental and treatment-related factors, including antiepileptic medications, seizure types and frequencies, disease severity, language dominance, and other initial precipitating factors. On average, duration of epilepsy was at least 10 years; longitudinal investigations of new-onset and paediatric epilepsies will provide a more comprehensive understanding. Despite using standardized image processing protocols, quality control, and statistical techniques, some brain measures showed a wide distribution of effect sizes across research centres, which may reflect sample heterogeneity and differences in scanning protocols (Supplementary material).
We observed modest thickness differences across the majority of cortical regions; Cohen's d effect sizes ranged from small to moderate (d = 0.2-0.5), with some very small effects (d 5 0.2) noted in the right pars opercularis, bilateral pars triangularis, and bilateral transverse temporal gyri of the aggregate all-epilepsies group. Other large-scale ENIGMA studies have reported similarly modest (albeit less widespread) cortical abnormalities in psychiatric illnesses including major depression (Schmaal et al., 2016) and bipolar disorder (Hibar et al., 2017b) . Although epilepsy is characterized by an enduring predisposition to generate abnormal excessive or synchronous neuronal activity in the brain (Fisher et al., 2014) , our findings indicate that common epilepsies are associated with widespread, but relatively subtle, structural alterations of the neocortex. Replication in independent MRI cohorts, complemented by advanced imaging modalities and large-scale gene expression datasets, will help elucidate how these cortical abnormalities relate to underlying disease processes.
Overall, in the largest neuroimaging analysis of epilepsy to date, we demonstrate a pattern of robust brain structural abnormalities within and between syndromes. Specific functional interpretations cannot be inferred from grey matter differences, but lower volume and thickness measures may reflect tissue loss, supporting recent observations that the common epilepsies cannot always be considered benign (Gaitatzis et al., 2004; Bell et al., 2016; Devinsky et al., 2017) . The study provides a macroscopic neuroanatomical map upon which neuropathological work, animal models, and further gene expression studies, can expand. Our consortium plans to investigate more specific neuroanatomical traits and epilepsy phenotypes, explore sophisticated shape and sulcal measures, and eventually conduct genome-wide association analysis of brain measures, to improve our understanding and treatment of the epilepsies.
Web resources
All image processing, quality assurance, and statistical analysis protocols for this study can be downloaded from the ENIGMA website, at: http://enigma.usc.edu/ongoing/ enigma-epilepsy/enigma-epilepsy-protocols/. 
